These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3487119)

  • 1. Penicillamine-induced proteinuria: risk factors.
    Stein HB; Schroeder ML; Dillon AM
    Semin Arthritis Rheum; 1986 May; 15(4):282-7. PubMed ID: 3487119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Dahlqvist SR; Ström H; Bjelle A; Möller E
    Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis.
    Bardin T; Dryll A; Debeyre N; Ryckewaert A; Legrand L; Marcelli A; Dausset J
    Ann Rheum Dis; 1982 Dec; 41(6):599-601. PubMed ID: 6959574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA associations in aurothioglucose- and D-penicillamine-induced haematotoxic reactions in rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP
    Tissue Antigens; 1985 Jul; 26(1):35-40. PubMed ID: 3929421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
    Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
    Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential gold and penicillamine therapy in rheumatoid arthritis.
    Halla JT; Cassady J; Hardin JG
    Am J Med; 1982 Mar; 72(3):423-6. PubMed ID: 6174045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between aurothioglucose- and D-penicillamine-induced proteinuria.
    Speerstra F; van de Putte LB; Rasker JJ; Reekers P; Vandenbroucke JP
    Scand J Rheumatol; 1984; 13(4):363-8. PubMed ID: 6441248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HLA system and complications of the treatment of rheumatoid polyarthritis with D-penicillamine].
    Bardin T; Dryll A; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):27-9. PubMed ID: 3486448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.
    Perrier P; Raffoux C; Thomas P; Tamisier JN; Busson M; Gaucher A; Streiff F
    Ann Rheum Dis; 1985 Sep; 44(9):621-4. PubMed ID: 3876081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA and disease manifestations in rheumatoid arthritis--a Canadian experience.
    Gladman DD; Anhorn KA
    J Rheumatol; 1986 Apr; 13(2):274-6. PubMed ID: 3459890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigens and drug toxicity in rheumatoid arthritis.
    Ford PM
    J Rheumatol; 1984 Jun; 11(3):259-61. PubMed ID: 6610749
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural course of penicillamine nephropathy: a long term study of 33 patients.
    Hall CL; Jawad S; Harrison PR; MacKenzie JC; Bacon PA; Klouda PT; MacIver AG
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1083-6. PubMed ID: 3132218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.